Saba Capital Management, L.P. Da32 Life Science Tech Acquisition Corp. Transaction History

Saba Capital Management, L.P.

  • $5.92 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$10.13 - $10.31 $179,138 - $182,322
-17,684 Reduced 1.41%
1,240,593 $12.7 Million
Q2 2022

Aug 15, 2022
BUY
$9.65 - $9.83 $1.33 Million - $1.36 Million
138,000 Added 12.32%
1,258,277 $12.2 Million
Q1 2022

May 16, 2022
BUY
$9.59 - $9.81 $10.7 Million - $11 Million
1,120,277 New
1,120,277 $10.9 Million

About DA32 Life Science Tech Acquisition Corp.

DALS Quotes by TradingView
  • Ticker DALS
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 20,650,000
  • Description
  • DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science...
More about DALS
Track This Portfolio

Track Saba Capital Management, L.P. Portfolio

Follow Saba Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saba Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Saba Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email